ClearanceBrief
Recall Z-1272-2013 ยท LTT Panels, Test, Susceptibility, Antimicrobial

Siemens Healthcare Diagnostics, Inc.

Siemens Healthcare Diagnostics Inc. MIcroScan MICroSTREP plus Type 1 B1027-201 panels. .MICroSTREP panels are designed for use in determining antimicrobial agent susceptibility of aerobic nonenterococcal streptococci (including Streptococcus pneumoniae) and Haemophilus spp.

DateMay 8, 2013 (initiated Mar 6, 2013)
StatusTerminated
ReasonCustomer complaint investigation confirmed the issue of false skipped wells and false susceptible misreads with A. agalactiae affecting multiple antimicrobial agents on MicroScan Microbiology Systems.
Root causeUnder Investigation by firm
ActionSiemens Healthcare sent a Urgent Field Safety Notification letter dated March 6, 2013, to all affected customers of MicroScan MICroSTREP plus type 1, who process panels in a Walk Away System. The letter identified the product the problem and the action needed to be taken by the customer. As stated in our product Instructions for Use, test results should be interpreted in conjunction with the patients medical history, clinical presentation and other findings. We recommend discussing the content of this letter with your laboratory director regarding the need to review previous test results,
Quantity21,608 boxes = 432,160 panels
DistributionUS Nationwide Distribution including Puerto Rico.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K091949MICROSCAN MICROSTREP PLUS, MODEL B1027-201
Siemens Healthcare Diagnostics, Jan 26, 2010